MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$12,728K
Free Cash flow
-$15,406K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from the issuance of co...
Proceeds from sales and maturiti...
Stock-based compensation
Others
Negative Cash Flow Breakdown
Purchase of short-term investmen...
Product manufacturing costs
Research and development
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenue
54,626
48,578
62,178
107,206
Product manufacturing costs
25,417
22,499
19,642
17,815
Stock based compensation and amortization expense
2,521
1,689
1,368
2,086
Other costs
3
3,552
3,716
2,965
Research and development
19,341
16,082
15,261
17,777
Sales and marketing
9,186
7,840
6,782
7,441
General and administrative
18,203
16,128
14,505
15,692
Total other income, net
2,056
2,299
3,495
2,590
Provision for (benefit from) income tax expense
125
552
414
72
Net loss
-18,114
-17,465
3,985
-21,733
Depreciation and amortization
3,233
2,703
2,074
2,053
Loss on write-off and disposal of property and equipment and right-of-use asset impairment
-
-
-
21
Loss on write-off and disposal of property and equipment
0
0
113
-
Gain on lease termination
0
-65
-
0
Stock-based compensation
11,385
7,494
7,271
11,829
Deferred taxes
211
360
-
-
Reduction of revenue related to stock warrant issued to customer
1,274
1,101
569
1,033
Amortization of right-of-use asset
843
820
1,240
1,359
Non-cash interest income
-
-
214
-
Accretion on short-term investments
661
454
839
912
Change in fair value of warrant liabilities
0
0
-118
-237
(recovery) provision for inventory write-down
436
-488
178
-1,016
(recovery) provision for doubtful accounts
-86
0
-128
-17
Realized gain on sale of investments
-
-
12
-
Realized gain on sale of available for sale securities
5
5
-
0
Accounts receivable
-4,171
-6,472
5,087
9,401
Inventory
1,987
3,665
7,230
1,594
Prepaid expenses and other assets
9,715
153
-2,374
2,303
Accounts payable
4,377
-3,536
3,986
2,791
Accrued and other liabilities
-90
134
-11,921
2,078
Contract liabilities
-6,620
1,020
-9,925
-538
Operating lease liability
-988
-895
-1,705
-1,755
Net cash used in operating activities
-12,758
-7,281
-15,426
-18,342
Proceeds from sale of property & equipment
-
-
0
0
Purchases of property and equipment
2,648
2,561
21,750
1,702
Purchase of short-term investments
111,505
10,802
31,189
38,738
Proceeds from sales and maturities of short-term investments
37,076
57,919
48,255
32,750
Acquisition of stereolabs, net of cash acquired
0
27,493
-
-
Net cash used in investing activities
-77,077
17,063
-4,684
-7,690
Proceeds from espp purchase
1,332
-
975
0
Proceeds from exercise of stock options
2,248
94
0
35
Repayments of borrowings
-
-
0
0
Payments received to fund employees tax obligation for vested rsus
1,018
611
-2,030
2,083
Proceeds from the issuance of common stock under at-the-market offering, net of commissions and fees
97,985
-
1,526
35,259
At-the-market offering costs for the issuance of common stock
20
-
189
222
Net cash provided by financing activities
102,563
705
282
37,155
Effect of exchange rates on cash and cash equivalents
0
0
42
-44
Net increase in cash, cash equivalents and restricted cash
12,728
10,487
-19,786
11,079
Cash, cash equivalents and restricted cash at beginning of period
80,467
69,980
89,766
48,099
Cash, cash equivalents and restricted cash at end of period
93,195
80,467
69,980
89,766
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from the
issuance of common stock...
$97,985K
(66.65%↑ Y/Y)
Proceeds from exercise of
stock options
$2,248K
(4583.33%↑ Y/Y)
Proceeds from espp
purchase
$1,332K
(35.92%↑ Y/Y)
Payments received to fund
employees tax obligation...
$1,018K
(185.15%↑ Y/Y)
Net cash provided by
financing activities
$102,563K
(70.45%↑ Y/Y)
Canceled cashflow
$20K
Net increase in
cash, cash...
$12,728K
(-58.39%↓ Y/Y)
Canceled cashflow
$89,835K
At-the-market offering costs
for the issuance of...
$20K
(100.00%↑ Y/Y)
Proceeds from sales and
maturities of short-term...
$37,076K
(-35.24%↓ Y/Y)
Stock-based compensation
$11,385K
(-47.59%↓ Y/Y)
Accounts payable
$4,377K
(-31.88%↓ Y/Y)
Accounts receivable
-$4,171K
(35.54%↑ Y/Y)
Depreciation and
amortization
$3,233K
(-11.52%↓ Y/Y)
Reduction of revenue
related to stock warrant...
$1,274K
(24.78%↑ Y/Y)
Amortization of right-of-use
asset
$843K
(-66.40%↓ Y/Y)
(recovery) provision for
inventory write-down
$436K
(-6.24%↓ Y/Y)
Net cash used in
investing activities
-$77,077K
(-222.81%↓ Y/Y)
Net cash used in
operating activities
-$12,758K
(-106.17%↓ Y/Y)
Canceled cashflow
$37,076K
Canceled cashflow
$25,719K
Total revenue
$54,626K
(-19.29%↓ Y/Y)
Total other income,
net
$2,056K
(-55.32%↓ Y/Y)
Purchase of short-term
investments
$111,505K
(39.93%↑ Y/Y)
Net loss
-$18,114K
(57.51%↑ Y/Y)
Purchases of property and
equipment
$2,648K
(83.76%↑ Y/Y)
Canceled cashflow
$56,682K
Prepaid expenses and
other assets
$9,715K
(166.90%↑ Y/Y)
Contract liabilities
-$6,620K
(-72.58%↓ Y/Y)
Inventory
$1,987K
(196.97%↑ Y/Y)
Operating lease liability
-$988K
(69.81%↑ Y/Y)
Accretion on short-term
investments
$661K
(-55.58%↓ Y/Y)
Deferred taxes
$211K
Accrued and other
liabilities
-$90K
(-102.26%↓ Y/Y)
(recovery) provision for
doubtful accounts
-$86K
(-162.77%↓ Y/Y)
Realized gain on sale of
available for sale...
$5K
(25.00%↑ Y/Y)
Product manufacturing
costs
$25,417K
(-16.85%↓ Y/Y)
Research and development
$19,341K
(-39.81%↓ Y/Y)
General and
administrative
$18,203K
(-47.15%↓ Y/Y)
Sales and marketing
$9,186K
(-31.45%↓ Y/Y)
Stock based
compensation and...
$2,521K
(-34.57%↓ Y/Y)
Provision for (benefit
from) income tax...
$125K
(103.65%↑ Y/Y)
Other costs
$3K
(-99.92%↓ Y/Y)
Buy us a coffee
Ouster, Inc. (OUST)
Ouster, Inc. (OUST)